Redo Announces $81 Million Series B to Support Commerce Technology Expansion

PUTTERY’S NEW MENU WORKS FOR THE 12 PM BIRTHDAY PARTY, THE 9 PM BACHELORETTE, AND EVERYONE IN BETWEEN

In this episode of Global Economic Press, Alex Brady delves into the innovative world of experiential entertainment with a spotlight on Puttery, a unique indoor mini-golf venue that is revolutionizing the dining experience. Puttery has recently launched a new menu across its ten United States locations, offering a diverse range of culinary delights that cater to various events and tastes. This menu refresh includes new shareables, entrees, artisan pizzas, desserts, signature cocktails, and an expanded zero-proof lineup, setting a new standard for combining leisure and gastronomy. The focus is on delivering a complete experience where the quality of food and drinks matches the creativity of the mini-golf courses. Puttery's new menu is designed to accommodate a wide array of occasions, from family-friendly birthday parties to lively bachelorette gatherings. The offerings include innovative dishes like Brisket Jalapeño Spring Rolls and Short Rib Pizza, alongside unique cocktails crafted by local bartenders in each city. The menu also adapts to regional tastes, with localized dishes and beverage programs available in select markets. As Kyle Rickman, President and Chief Operating Officer of Golf Entertainment Group, states, the new menu reflects Puttery's commitment to providing a comprehensive entertainment experience. For more information about Puttery and its offerings, visit their website at Puttery [https://www.puttery.com/].

TWL Announces Expanded Online Access to GLP-1 Weight-Loss Care With Insurance and Self-Pay Options

In this episode of Global Economic Press, Alex Brady delves into the healthcare sector's latest advancements, spotlighting TWL's significant announcement about expanding online access to GLP-1 weight-loss care. This initiative is designed to assist patients in navigating weight-management solutions through insurance-supported brand-name medications or self-pay options. The program offers a comprehensive approach, combining virtual medical evaluations, prescription management, insurance coordination, and weight-loss coaching. TWL aims to simplify the weight-management process for patients uncertain about insurance coverage or self-pay options, potentially reshaping the healthcare landscape. TWL's program provides insurance support for brand-name GLP-1 medications, assisting patients with insurance verification and prior-authorization requirements. For those without insurance coverage, self-pay treatment pathways are available, including compounded semaglutide and tirzepatide options. The program begins with an online medical assessment, followed by personalized treatment recommendations and ongoing care. TWL's broader platform also offers virtual care for various healthcare needs. For more information about TWL's services, visit their website at TopWeightLossMed.com [https://topweightlossmed.com].

FitRx Expands Online Weight-Management Program With Needle-Free Oral Semaglutide Option

In this episode of Global Economic Press, Alex Brady discusses the recent expansion of FitRx's online weight-management program, which now includes a needle-free oral semaglutide option. This development provides an alternative for patients who are hesitant about injectable treatments. The program offers a comprehensive approach to weight management, combining online medical assessments, provider reviews, ongoing clinical support, and pharmacy delivery through a single virtual platform. FitRx continues to offer additional weight-management pathways, including injectable treatment options and assistance with insurance coverage for certain Food and Drug Administration-approved medications when clinically appropriate. The expanded FitRx program includes services such as personalized weight-management plans, prescription and refill management, secure messaging with the care team, and ongoing medical supervision. Patients can also explore alternative treatment pathways, including compounded injectable semaglutide and tirzepatide, as well as non-GLP-1 prescription options. Pricing and availability vary by state, and the program emphasizes the importance of medical oversight and patient safety. For more information about FitRx and its services, visit FitRx's website [https://fitrxapp.com].

Zealthy Launches Dedicated Tirzepatide Care Pathway for Weight-Management Patients

In this episode of Global Economic Press, Alex Brady discusses a significant advancement in the healthcare sector with the launch of Zealthy's dedicated tirzepatide care pathway for weight-management patients. Zealthy, a leading online healthcare platform, has introduced this new workflow to streamline the process for patients and healthcare providers. The pathway centralizes the steps involved in evaluating eligible patients for prescription tirzepatide treatment, including an online medical assessment, review by a licensed healthcare provider, insurance coordination, prescription management, and ongoing clinical communication. This initiative aims to enhance the efficiency and effectiveness of weight-management care, ensuring that patients receive timely and appropriate treatment. The tirzepatide care pathway is integrated into Zealthy's existing virtual weight-management program, offering a comprehensive approach to patient care. Patients begin by completing an online medical assessment, which is reviewed by a licensed healthcare provider to determine the suitability of tirzepatide or other treatments. The pathway also includes support for insurance authorization and prescription management, although Zealthy does not guarantee medication coverage or specific treatment outcomes. This innovative approach underscores Zealthy's commitment to providing accessible and coordinated healthcare services. For more information about Zealthy and its services, visit their website at https://getzealthy.com [https://getzealthy.com].

Zealthy Expands Online Access to Ozempic Evaluations and Insurance Support for Eligible Patients With Type 2 Diabetes

In this episode of Global Economic Press, Alex Brady explores the innovative telehealth platform Zealthy and its recent expansion to provide online access to Ozempic evaluations and insurance support for eligible patients with Type 2 Diabetes. Zealthy connects patients with licensed healthcare providers, offering a convenient alternative to traditional in-person appointments. The platform allows patients to complete medical assessments from home, receive guidance on medication eligibility, and manage prescriptions and insurance coordination. This expansion aims to transform diabetes management by making it more accessible and efficient for patients. Zealthy's program offers a comprehensive approach, including remote medical evaluations, ongoing provider support, and assistance with insurance and prior-authorization processes. While the introductory membership fee is $39, patients should be aware of the regular $135 monthly membership cost and the separate expense of Ozempic, which may be reduced by insurance coverage. It is crucial to note that Ozempic is primarily a diabetes medication, not an FDA-approved weight-loss drug. Patients interested in weight management should consider other options like Wegovy. For more information about Zealthy and its services, visit their website at Zealthy [https://getzealthy.com].